Loading...

Invitae Corporation

NVTA•NYSE
Healthcare
Medical - Diagnostics & Research
$0.02
$-0.01(-35.59%)

Invitae Corporation (NVTA) Stock Overview

Explore Invitae Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 62.6/100

Key Financials

Market Cap5.4M
P/E Ratio-0.00
EPS (TTM)$-5.36
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

NVTA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Invitae Corporation (NVTA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 5.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;